Form 4 holding
Director
HERON THERAPEUTICS, INC. /DE/
- Security class
- Common Stock
- Shares / value
- 540,000
- Estimated value
- $1,161,000
- Report date
- 22 Feb 2023
- Price
- $2.15
- Ownership
- By Broadfin Holdings LLC
Kevin Kotler - Director at HERON THERAPEUTICS, INC. /DE/
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- HRTX on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Kevin Kotler since 19 Aug 2025
Reported holdings for Kevin Kotler in HERON THERAPEUTICS, INC. /DE/
Form 4 holding
Director
HERON THERAPEUTICS, INC. /DE/
- Security class
- Common Stock
- Shares / value
- 37,879
- Estimated value
- $81,440
- Report date
- 22 Feb 2023
- Price
- $2.15
- Ownership
- Direct
Transaction history for Kevin Kotler in HERON THERAPEUTICS, INC. /DE/
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.